Brokerages Set IonQ, Inc. (NYSE:IONQ) PT at $69.46

IonQ, Inc. (NYSE:IONQ) has received a consensus rating of “Moderate Buy” from the fourteen ratings firms that are presently covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, four have assigned a hold recommendation and nine have assigned a buy recommendation to the company. The average 1 year price target among brokerages that have updated their coverage on the stock in the last year is $69.9167.

Several brokerages recently commented on IONQ. Morgan Stanley set a $49.00 price target on shares of IonQ in a report on Thursday. Benchmark reaffirmed a “buy” rating and set a $60.00 price objective on shares of IonQ in a report on Thursday. Jefferies Financial Group set a $75.00 target price on shares of IonQ in a research report on Thursday. Rosenblatt Securities reissued a “buy” rating and set a $100.00 target price on shares of IonQ in a research note on Thursday. Finally, JPMorgan Chase & Co. raised their price target on shares of IonQ from $42.00 to $50.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th.

IonQ Price Performance

NYSE IONQ opened at $44.48 on Friday. The stock’s fifty day moving average price is $47.97 and its 200 day moving average price is $43.32. IonQ has a 1 year low of $25.89 and a 1 year high of $84.64. The company has a market cap of $16.60 billion, a price-to-earnings ratio of -9.55 and a beta of 3.28.

IonQ (NYSE:IONQ) last announced its quarterly earnings data on Wednesday, August 5th. The company reported ($0.33) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.56) by $0.23. IonQ had a negative return on equity of 21.75% and a negative net margin of 553.27%.The business had revenue of $80.05 million for the quarter, compared to analyst estimates of $66.47 million. During the same period in the prior year, the company earned ($0.70) earnings per share. The company’s revenue was up 286.7% on a year-over-year basis. Research analysts expect that IonQ will post -2.26 earnings per share for the current year.

More IonQ News

Here are the key news stories impacting IonQ this week:

• Positive Sentiment: Record quarterly results and raised outlook: IonQ reported second-quarter revenue of approximately $80.1 million, up 287% year over year and above expectations. The company also raised its 2026 revenue outlook to $280 million–$290 million, reinforcing the view that demand is accelerating. IONQ Q2 Earnings Miss Estimates, Revenues Beat, Stock Rises
• Positive Sentiment: Defense business is expanding: DARPA awarded IonQ a $28 million contract extension, with a potential additional $30 million option, to produce 125 next-generation optical atomic clocks. Separately, IonQ’s Capella space division won an NRO contract for commercial synthetic-aperture-radar data supporting national-security missions. These awards add revenue visibility and strengthen IonQ’s government customer base. DARPA Selects IonQ to Produce Next-Generation Atomic Clocks
• Positive Sentiment: Strategic growth initiatives gained attention: The $1.8 billion SkyWater Technology acquisition is supporting IonQ’s vertically integrated quantum roadmap, including a planned 256-qubit system. Reported remaining performance obligations reached $485 million, while new grid, networking and cybersecurity projects broaden the company’s commercial opportunity. IonQ Sparks a Quantum Grid Revolution
• Positive Sentiment: Analyst sentiment remains bullish: Benchmark, Needham, Cantor Fitzgerald and Rosenblatt reaffirmed positive ratings, with price targets ranging from $60 to $100, helping support the rebound in speculative quantum stocks.
• Neutral Sentiment: IonQ remains a high-volatility, unprofitable growth stock. Analysts see substantial long-term upside if quantum adoption reaches commercial milestones, but the shares are still well below their 52-week high and the company continues to post significant losses. What Sent IonQ Shares Surging and Whether the Momentum Can Last
• Negative Sentiment: IonQ filed a prospectus supplement related to a secondary share resale, which could increase the available share supply and create dilution or selling-pressure concerns. Investors are also still mindful of the stock’s 31.6% July decline and the risk that enthusiasm may fade if quantum commercialization takes longer than expected. IonQ Files Prospectus Supplement for Secondary Share Resale

Insider Activity at IonQ

In other news, Director Kathryn K. Chou sold 2,757 shares of the stock in a transaction dated Thursday, June 18th. The shares were sold at an average price of $55.02, for a total value of $151,690.14. Following the completion of the sale, the director directly owned 62,608 shares in the company, valued at $3,444,692.16. This represents a 4.22% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider John W. Raymond sold 3,815 shares of the firm’s stock in a transaction dated Thursday, June 18th. The stock was sold at an average price of $55.01, for a total transaction of $209,863.15. Following the completion of the transaction, the insider directly owned 80,148 shares in the company, valued at approximately $4,408,941.48. This represents a 4.54% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders sold 9,329 shares of company stock valued at $513,216. 0.55% of the stock is owned by insiders.

Institutional Investors Weigh In On IonQ

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. purchased a new position in IonQ during the second quarter worth about $1,112,945,000. Vanguard Group Inc. boosted its holdings in IonQ by 18.5% in the 4th quarter. Vanguard Group Inc. now owns 34,774,743 shares of the company’s stock valued at $1,560,343,000 after purchasing an additional 5,420,037 shares during the last quarter. Norges Bank purchased a new stake in shares of IonQ in the 4th quarter valued at approximately $199,753,000. Marex Group plc grew its stake in shares of IonQ by 419.1% in the 4th quarter. Marex Group plc now owns 4,083,453 shares of the company’s stock valued at $183,225,000 after buying an additional 3,296,866 shares during the period. Finally, State Street Corp increased its holdings in shares of IonQ by 42.3% during the 4th quarter. State Street Corp now owns 8,962,789 shares of the company’s stock worth $402,160,000 after buying an additional 2,663,230 shares during the last quarter. Institutional investors and hedge funds own 41.42% of the company’s stock.

About IonQ

IonQ, Inc engages in the development of general-purpose quantum computing systems in the United States. It sells access to quantum computers of various qubit capacities. The company makes access to its quantum computers through cloud platforms, such as Amazon Web Services (AWS) Amazon Braket, Microsoft’s Azure Quantum, and Google’s Cloud Marketplace, as well as through its cloud service. It also provides contracts associated with the design, development, and construction of specialized quantum computing hardware systems; maintenance and support services; and consulting services related to co-developing algorithms on quantum computing systems.